Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 289

1.

Data must be shared-also with researchers outside of Europe.

Ursin G, Stenbeck M, Chang-Claude J, Gunter M, Kaaks R, Kampman E, Lambe M, van Leeuwen F, Magnusson P, Malila N, Nilbert MC, Romundstad PR, Röösli M, Ryel AL, Dos-Santos-Silva I, Storm HH, Swerdlow A, Vineis P, Knudsen GPS.

Lancet. 2019 Nov 23;394(10212):1902-1903. doi: 10.1016/S0140-6736(19)32633-9. Epub 2019 Nov 7. No abstract available.

PMID:
31708191
2.

Sharing data safely while preserving privacy.

Ursin G, Malila N, Chang-Claude J, Gunter M, Kaaks R, Kampman E, Lambe M, van Leeuwen F, Magnusson P, Nilbert MC, Romundstad PR, Röösli M, Ryel AL, Dos-Santos-Silva I, Stenbeck M, Storm HH, Swerdlow A, Vineis P, Knudsen GPS.

Lancet. 2019 Nov 23;394(10212):1902. doi: 10.1016/S0140-6736(19)32603-0. Epub 2019 Nov 7. No abstract available.

PMID:
31708190
3.

Author's reply to: "Detection by screening introduces biases into survival estimates for luminal A-like breast cancer patients".

Johansson ALV, Ursin G.

Int J Cancer. 2019 Oct 1. doi: 10.1002/ijc.32699. [Epub ahead of print] No abstract available.

PMID:
31576557
4.

Cancer registration in the era of modern oncology and GDPR.

Ursin G.

Acta Oncol. 2019 Nov;58(11):1547-1548. doi: 10.1080/0284186X.2019.1657586. Epub 2019 Aug 30. No abstract available.

PMID:
31469347
5.

Pre-diagnosis alcohol consumption and mortality risk among black women and white women with invasive breast cancer.

Ma H, Malone KE, McDonald JA, Marchbanks PA, Ursin G, Strom BL, Simon MS, Sullivan-Halley J, Bernstein L, Lu Y.

BMC Cancer. 2019 Aug 13;19(1):800. doi: 10.1186/s12885-019-5991-8.

6.

Number of Risky Lifestyle Behaviors and Breast Cancer Risk.

Ellingjord-Dale M, Vos L, Vik Hjerkind K, Hjartåker A, Russnes HG, Tretli S, Hofvind S, Dos-Santos-Silva I, Ursin G.

JNCI Cancer Spectr. 2018 Jul 19;2(3):pky030. doi: 10.1093/jncics/pky030. eCollection 2018 Jul.

7.

Important outcomes of moral case deliberation: a Euro-MCD field survey of healthcare professionals' priorities.

Svantesson M, de Snoo-Trimp JC, Ursin G, de Vet HC, Brinchmann BS, Molewijk B.

J Med Ethics. 2019 Sep;45(9):608-616. doi: 10.1136/medethics-2018-104745. Epub 2019 Jul 18.

8.

Risk of breast cancer by prior screening results among women participating in BreastScreen Norway.

Lilleborge M, Falk RS, Russnes H, Sauer T, Ursin G, Hofvind S.

Cancer. 2019 Oct 1;125(19):3330-3337. doi: 10.1002/cncr.32330. Epub 2019 Jun 17.

PMID:
31206638
9.

Correction to: Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania.

Andreassen T, Melnic A, Figueiredo R, Moen K, Şuteu O, Nicula F, Ursin G, Weiderpass E.

Int J Public Health. 2019 Jul;64(6):977-978. doi: 10.1007/s00038-019-01263-8.

PMID:
31197406
10.

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, Robbins HA, Pawlita M, Langseth H, Schlecht NF, Tinker LF, Agalliu I, Smoller SW, Ness-Jensen E, Hveem K, D'Souza G, Visvanathan K, May B, Ursin G, Weiderpass E, Giles GG, Milne RL, Cai Q, Blot WJ, Zheng W, Weinstein SJ, Albanes D, Brenner N, Hoffman-Bolton J, Kaaks R, Barricarte A, Tjønneland A, Sacerdote C, Trichopoulou A, Vermeulen RCH, Huang WY, Freedman ND, Brennan P, Waterboer T, Johansson M.

Ann Oncol. 2019 Jun 11. pii: mdz138. doi: 10.1093/annonc/mdz138. [Epub ahead of print]

11.

Field-testing the Euro-MCD Instrument: Experienced outcomes of moral case deliberation.

de Snoo-Trimp JC, Molewijk B, Ursin G, Brinchmann BS, Widdershoven GA, de Vet HC, Svantesson M.

Nurs Ethics. 2019 Jun 9:969733019849454. doi: 10.1177/0969733019849454. [Epub ahead of print]

PMID:
31177947
12.

Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study.

Andreassen BK, Støer NC, Martinsen JI, Ursin G, Weiderpass E, Thoresen GH, Debernard KB, Karlstad Ø, Pottegard A, Friis S.

BMJ Open. 2019 Apr 8;9(4):e028504. doi: 10.1136/bmjopen-2018-028504.

13.

Continuous development of colorectal cancer screening programs.

Hoff G, Ursin G, Løberg M, de Lange T, Skovlund E, Holme Ø.

Acta Oncol. 2019 Jun;58(6):822-823. doi: 10.1080/0284186X.2019.1588475. Epub 2019 Apr 3.

PMID:
30939973
14.
15.

Correction: Cancer trends and population structure in Norway 1990–2016.

Hjerkind KV, Larsen IK, Møller B, Ursin G.

Tidsskr Nor Laegeforen. 2018 Nov 28;138(1). doi: 10.4045/tidsskr.18.0916. Print 2019 Jan 15. Norwegian. No abstract available.

16.

A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.

Bergholtz H, Lien TG, Ursin G, Holmen MM, Helland Å, Sørlie T, Haakensen VD.

J Mammary Gland Biol Neoplasia. 2019 Jun;24(2):163-175. doi: 10.1007/s10911-018-09423-x. Epub 2019 Jan 6.

PMID:
30613869
17.

Adjusting for BMI in analyses of volumetric mammographic density and breast cancer risk.

Hudson S, Vik Hjerkind K, Vinnicombe S, Allen S, Trewin C, Ursin G, Dos-Santos-Silva I, De Stavola BL.

Breast Cancer Res. 2018 Dec 29;20(1):156. doi: 10.1186/s13058-018-1078-8.

18.

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high-risk human papilloma virus testing.

Andreassen T, Hansen BT, Engesaeter B, Hashim D, Støer NC, Tropé A, Moen K, Ursin G, Weiderpass E.

Int J Cancer. 2019 Jul 1;145(1):29-39. doi: 10.1002/ijc.32067. Epub 2019 Jan 4.

19.

Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies.

Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, Milne RL, Pala V, Palmer JR, Peeters PH, Riboli E, Sund M, Tamimi RM, Tjønneland A, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Wolk A, Zheng W, Weinberg CR, Swerdlow AJ, Sandler DP.

Ann Intern Med. 2019 Jan 1;170(1):22-30. doi: 10.7326/M18-1323. Epub 2018 Dec 11.

20.

Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity.

Rounge TB, Umu SU, Keller A, Meese E, Ursin G, Tretli S, Lyle R, Langseth H.

Sci Rep. 2018 Dec 5;8(1):17650. doi: 10.1038/s41598-018-35974-4.

21.

Cancer trends and population structure in Norway 1990-2016.

Hjerkind KV, Larsen IK, Møller B, Ursin G.

Tidsskr Nor Laegeforen. 2018 Nov 22;138(19). doi: 10.4045/tidsskr.17.0938. Print 2018 Nov 27. English, Norwegian. Erratum in: Tidsskr Nor Laegeforen. 2018 Nov 28;138(1):.

22.

A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk.

Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, Trichopoulou A, Gunter MJ, Tsilidis KK, Sánchez MJ, Olsen A, Brenner H, Schöttker B, Perna L, Holleczek B, Knekt P, Rissanen H, Yeap BB, Flicker L, Almeida OP, Wong YYE, Chan JM, Giovannucci EL, Stampfer MJ, Ursin G, Gislefoss RE, Bjørge T, Meyer HE, Blomhoff R, Tsugane S, Sawada N, English DR, Eyles DW, Heath AK, Williamson EJ, Manjer J, Malm J, Almquist M, Marchand LL, Haiman CA, Wilkens LR, Schenk JM, Tangen CM, Black A, Cook MB, Huang WY, Ziegler RG, Martin RM, Hamdy FC, Donovan JL, Neal DE, Touvier M, Hercberg S, Galan P, Deschasaux M, Key TJ, Allen NE.

Cancer Res. 2019 Jan 1;79(1):274-285. doi: 10.1158/0008-5472.CAN-18-2318. Epub 2018 Nov 13.

23.

Growth factor genes and change in mammographic density after stopping combined hormone therapy in the California Teachers Study.

Lee E, Luo J, Schumacher FR, Van Den Berg D, Wu AH, Stram DO, Bernstein L, Ursin G.

BMC Cancer. 2018 Nov 6;18(1):1072. doi: 10.1186/s12885-018-4981-6.

24.

Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.

Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G.

Int J Cancer. 2019 Mar 15;144(6):1251-1261. doi: 10.1002/ijc.31950. Epub 2018 Dec 3.

PMID:
30367449
25.

Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life.

Sandvei MS, Vatten LJ, Bjelland EK, Eskild A, Hofvind S, Ursin G, Opdahl S.

Eur J Epidemiol. 2019 Mar;34(3):267-278. doi: 10.1007/s10654-018-0431-7. Epub 2018 Aug 6.

PMID:
30083811
26.

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.

Watts EL, Appleby PN, Perez-Cornago A, Bueno-de-Mesquita HB, Chan JM, Chen C, Cohn BA, Cook MB, Flicker L, Freedman ND, Giles GG, Giovannucci E, Gislefoss RE, Hankey GJ, Kaaks R, Knekt P, Kolonel LN, Kubo T, Le Marchand L, Luben RN, Luostarinen T, Männistö S, Metter EJ, Mikami K, Milne RL, Ozasa K, Platz EA, Quirós JR, Rissanen H, Sawada N, Stampfer M, Stanczyk FZ, Stattin P, Tamakoshi A, Tangen CM, Thompson IM, Tsilidis KK, Tsugane S, Ursin G, Vatten L, Weiss NS, Yeap BB, Allen NE, Key TJ, Travis RC.

Eur Urol. 2018 Nov;74(5):585-594. doi: 10.1016/j.eururo.2018.07.024. Epub 2018 Aug 1.

27.

Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.

Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Hankinson SE, Kaaks R, Key TJ, Kirsh VA, Kitahara CM, Koh WP, Larsson SC, Linet MS, Ma H, Masala G, Merritt MA, Milne RL, Overvad K, Ozasa K, Palmer JR, Peeters PH, Riboli E, Rohan TE, Sadakane A, Sund M, Tamimi RM, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Yuan JM, Zeleniuch-Jacquotte A, Sandler DP, Swerdlow AJ.

JAMA Oncol. 2018 Nov 1;4(11):e181771. doi: 10.1001/jamaoncol.2018.1771. Epub 2018 Nov 8.

28.

Volumetric Mammographic Density, Age-Related Decline, and Breast Cancer Risk Factors in a National Breast Cancer Screening Program.

Hjerkind KV, Ellingjord-Dale M, Johansson ALV, Aase HS, Hoff SR, Hofvind S, Fagerheim S, Dos-Santos-Silva I, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2018 Sep;27(9):1065-1074. doi: 10.1158/1055-9965.EPI-18-0151. Epub 2018 Jun 20.

29.

Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA.

J Natl Cancer Inst. 2019 Feb 1;111(2):158-169. doi: 10.1093/jnci/djy087.

30.

Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G; NORCCAP Study Group†.

Ann Intern Med. 2018 Jun 5;168(11):775-782. doi: 10.7326/M17-1441. Epub 2018 Apr 24.

31.

Attendance to cervical cancer screening among Roma and non-Roma women living in North-Western region of Romania.

Andreassen T, Melnic A, Figueiredo R, Moen K, Şuteu O, Nicula F, Ursin G, Weiderpass E.

Int J Public Health. 2018 Jun;63(5):609-619. doi: 10.1007/s00038-018-1107-5. Epub 2018 Apr 27. Erratum in: Int J Public Health. 2019 Jun 14;:.

PMID:
29704009
32.

Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.

Ma H, Ursin G, Xu X, Lee E, Togawa K, Malone KE, Marchbanks PA, McDonald JA, Simon MS, Folger SG, Lu Y, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.

Breast Cancer Res. 2018 Jan 22;20(1):5. doi: 10.1186/s13058-017-0931-5.

33.

Nordic Cancer Registries - an overview of their procedures and data comparability.

Pukkala E, Engholm G, Højsgaard Schmidt LK, Storm H, Khan S, Lambe M, Pettersson D, Ólafsdóttir E, Tryggvadóttir L, Hakanen T, Malila N, Virtanen A, Johannesen TB, Larønningen S, Ursin G.

Acta Oncol. 2018 Apr;57(4):440-455. doi: 10.1080/0284186X.2017.1407039. Epub 2017 Dec 11.

PMID:
29226751
34.

Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.

Botteri E, Støer NC, Sakshaug S, Graff-Iversen S, Vangen S, Hofvind S, de Lange T, Bagnardi V, Ursin G, Weiderpass E.

BMJ Open. 2017 Nov 15;7(11):e017639. doi: 10.1136/bmjopen-2017-017639.

35.

Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.

Moshina N, Roman M, Waade GG, Sebuødegård S, Ursin G, Hofvind S.

Eur Radiol. 2018 Apr;28(4):1662-1672. doi: 10.1007/s00330-017-5104-5. Epub 2017 Nov 2.

PMID:
29098437
36.

Optimalisering gjennom randomisering.

Hoff G, Lange T, Ursin G.

Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0876. Print 2017 Oct 31. Norwegian. No abstract available.

PMID:
29094557
Free Article
37.

Association analysis identifies 65 new breast cancer risk loci.

Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, Wang Z, Allen J, Keeman R, Eilber U, French JD, Qing Chen X, Fachal L, McCue K, McCart Reed AE, Ghoussaini M, Carroll JS, Jiang X, Finucane H, Adams M, Adank MA, Ahsan H, Aittomäki K, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Arun B, Auer PL, Bacot F, Barrdahl M, Baynes C, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bernstein L, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Børresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Brinton L, Broberg P, Brock IW, Broeks A, Brooks-Wilson A, Brucker SY, Brüning T, Burwinkel B, Butterbach K, Cai Q, Cai H, Caldés T, Canzian F, Carracedo A, Carter BD, Castelao JE, Chan TL, David Cheng TY, Seng Chia K, Choi JY, Christiansen H, Clarke CL; NBCS Collaborators, Collée M, Conroy DM, Cordina-Duverger E, Cornelissen S, Cox DG, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Devilee P, Doheny KF, Dörk T, Dos-Santos-Silva I, Dumont M, Durcan L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Ellberg C, Elvira M, Engel C, Eriksson M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fritschi L, Gaborieau V, Gabrielson M, Gago-Dominguez M, Gao YT, Gapstur SM, García-Sáenz JA, Gaudet MM, Georgoulias V, Giles GG, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grenaker Alnæs GI, Grip M, Gronwald J, Grundy A, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hamann U, Hamel N, Hankinson S, Harrington P, Hart SN, Hartikainen JM, Hartman M, Hein A, Heyworth J, Hicks B, Hillemanns P, Ho DN, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Hou MF, Hsiung CN, Huang G, Humphreys K, Ishiguro J, Ito H, Iwasaki M, Iwata H, Jakubowska A, Janni W, John EM, Johnson N, Jones K, Jones M, Jukkola-Vuorinen A, Kaaks R, Kabisch M, Kaczmarek K, Kang D, Kasuga Y, Kerin MJ, Khan S, Khusnutdinova E, Kiiski JI, Kim SW, Knight JA, Kosma VM, Kristensen VN, Krüger U, Kwong A, Lambrechts D, Le Marchand L, Lee E, Lee MH, Lee JW, Neng Lee C, Lejbkowicz F, Li J, Lilyquist J, Lindblom A, Lissowska J, Lo WY, Loibl S, Long J, Lophatananon A, Lubinski J, Luccarini C, Lux MP, Ma ESK, MacInnis RJ, Maishman T, Makalic E, Malone KE, Kostovska IM, Mannermaa A, Manoukian S, Manson JE, Margolin S, Mariapun S, Martinez ME, Matsuo K, Mavroudis D, McKay J, McLean C, Meijers-Heijboer H, Meindl A, Menéndez P, Menon U, Meyer J, Miao H, Miller N, Taib NAM, Muir K, Mulligan AM, Mulot C, Neuhausen SL, Nevanlinna H, Neven P, Nielsen SF, Noh DY, Nordestgaard BG, Norman A, Olopade OI, Olson JE, Olsson H, Olswold C, Orr N, Pankratz VS, Park SK, Park-Simon TW, Lloyd R, Perez JIA, Peterlongo P, Peto J, Phillips KA, Pinchev M, Plaseska-Karanfilska D, Prentice R, Presneau N, Prokofyeva D, Pugh E, Pylkäs K, Rack B, Radice P, Rahman N, Rennert G, Rennert HS, Rhenius V, Romero A, Romm J, Ruddy KJ, Rüdiger T, Rudolph A, Ruebner M, Rutgers EJT, Saloustros E, Sandler DP, Sangrajrang S, Sawyer EJ, Schmidt DF, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schumacher F, Schürmann P, Scott RJ, Scott C, Seal S, Seynaeve C, Shah M, Sharma P, Shen CY, Sheng G, Sherman ME, Shrubsole MJ, Shu XO, Smeets A, Sohn C, Southey MC, Spinelli JJ, Stegmaier C, Stewart-Brown S, Stone J, Stram DO, Surowy H, Swerdlow A, Tamimi R, Taylor JA, Tengström M, Teo SH, Beth Terry M, Tessier DC, Thanasitthichai S, Thöne K, Tollenaar RAEM, Tomlinson I, Tong L, Torres D, Truong T, Tseng CC, Tsugane S, Ulmer HU, Ursin G, Untch M, Vachon C, van Asperen CJ, Van Den Berg D, van den Ouweland AMW, van der Kolk L, van der Luijt RB, Vincent D, Vollenweider J, Waisfisz Q, Wang-Gohrke S, Weinberg CR, Wendt C, Whittemore AS, Wildiers H, Willett W, Winqvist R, Wolk A, Wu AH, Xia L, Yamaji T, Yang XR, Har Yip C, Yoo KY, Yu JC, Zheng W, Zheng Y, Zhu B, Ziogas A, Ziv E; ABCTB Investigators; ConFab/AOCS Investigators, Lakhani SR, Antoniou AC, Droit A, Andrulis IL, Amos CI, Couch FJ, Pharoah PDP, Chang-Claude J, Hall P, Hunter DJ, Milne RL, García-Closas M, Schmidt MK, Chanock SJ, Dunning AM, Edwards SL, Bader GD, Chenevix-Trench G, Simard J, Kraft P, Easton DF.

Nature. 2017 Nov 2;551(7678):92-94. doi: 10.1038/nature24284. Epub 2017 Oct 23.

38.

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway.

Leinonen MK, Campbell S, Ursin G, Tropé A, Nygård M.

Eur J Public Health. 2017 Oct 1;27(5):873-879. doi: 10.1093/eurpub/ckx093.

39.

[Safe implementation of HPV testing in the Norwegian Cervical Cancer Screening Programme].

Tropé A, Engesæter B, Nygård M, Andreassen T, Lönnberg S, Ursin G.

Tidsskr Nor Laegeforen. 2017 Sep 18;137(17). doi: 10.4045/tidsskr.17.0306. Print 2017 Sep 19. Norwegian. No abstract available.

40.

A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.

Samavat H, Ursin G, Emory TH, Lee E, Wang R, Torkelson CJ, Dostal AM, Swenson K, Le CT, Yang CS, Yu MC, Yee D, Wu AH, Yuan JM, Kurzer MS.

Cancer Prev Res (Phila). 2017 Dec;10(12):710-718. doi: 10.1158/1940-6207.CAPR-17-0187. Epub 2017 Sep 13.

41.

Care-managers' professional choices: ethical dilemmas and conflicting expectations.

Tønnessen S, Ursin G, Brinchmann BS.

BMC Health Serv Res. 2017 Sep 7;17(1):630. doi: 10.1186/s12913-017-2578-4.

42.

Alcohol, Physical Activity, Smoking, and Breast Cancer Subtypes in a Large, Nested Case-Control Study from the Norwegian Breast Cancer Screening Program.

Ellingjord-Dale M, Vos L, Hjerkind KV, Hjartåker A, Russnes HG, Tretli S, Hofvind S, Dos-Santos-Silva I, Ursin G.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1736-1744. doi: 10.1158/1055-9965.EPI-17-0611. Epub 2017 Sep 6.

43.

Dynamiske screeningprogrammer.

Ursin G, Hofvind S, Tropé A.

Tidsskr Nor Laegeforen. 2017 Aug 21;137(14-15). doi: 10.4045/tidsskr.17.0576. Print 2017 Aug 22. Norwegian. No abstract available.

PMID:
28828792
Free Article
44.

Protecting Privacy in Large Datasets-First We Assess the Risk; Then We Fuzzy the Data.

Ursin G, Sen S, Mottu JM, Nygård M.

Cancer Epidemiol Biomarkers Prev. 2017 Aug 1;26(8):1219-1224. doi: 10.1158/1055-9965.EPI-17-0172. Epub 2017 Jul 28.

45.

Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?

Botteri E, Støer NC, Sakshaug S, Graff-Iversen S, Vangen S, Hofvind S, Ursin G, Weiderpass E.

Int J Cancer. 2017 Nov 1;141(9):1763-1770. doi: 10.1002/ijc.30878. Epub 2017 Jul 19.

46.

Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.

Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, López-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schüz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V.

PLoS Med. 2017 Jun 30;14(6):e1002335. doi: 10.1371/journal.pmed.1002335. eCollection 2017 Jun.

47.

Comparison of subjective and fully automated methods for measuring mammographic density.

Moshina N, Roman M, Sebuødegård S, Waade GG, Ursin G, Hofvind S.

Acta Radiol. 2018 Feb;59(2):154-160. doi: 10.1177/0284185117712540. Epub 2017 May 31.

PMID:
28565960
48.

Sigmoidoscopy and faecal occult blood test - a comparative screening trial.

Lange T, Randel KR, Schult AL, Knudsen MD, Kirkøen B, Botteri E, Berstad P, Jørgensen A, Ursin G, Bretthauer M, Hoff G.

Tidsskr Nor Laegeforen. 2017 May 23;137(10):727-730. doi: 10.4045/tidsskr.16.1031. eCollection 2017 May. English, Norwegian. No abstract available.

49.

Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.

Andreassen T, Weiderpass E, Nicula F, Suteu O, Itu A, Bumbu M, Tincu A, Ursin G, Moen K.

Soc Sci Med. 2017 Jun;183:48-55. doi: 10.1016/j.socscimed.2017.04.040. Epub 2017 Apr 26.

50.

Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.

Byrne C, Ursin G, Martin CF, Peck JD, Cole EB, Zeng D, Kim E, Yaffe MD, Boyd NF, Heiss G, McTiernan A, Chlebowski RT, Lane DS, Manson JE, Wactawski-Wende J, Pisano ED.

J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.

Supplemental Content

Support Center